Đang chuẩn bị liên kết để tải về tài liệu:
Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-tomesenchymal transition

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Pancreatic ductal adenocarcinoma (PDAC) patients suffer poor outcomes, including a five-year survival of below 10%. Poor outcomes result in part from therapeutic resistance that limits the impact of cytotoxic first-line therapy. Novel therapeutic approaches are needed, but currently no targeted therapies exist to treat PDAC. |

TÀI LIỆU LIÊN QUAN

A benchmark of algorithms for the analysis of pooled CRISPR screens

CRISPhieRmix: A hierarchical mixture model for CRISPR pooled screens

A genome-scale CRISPR interference guide library enables comprehensive phenotypic profiling in yeast

Identification of functional regulatory elements in the human genome using pooled CRISPR screens

Pooled extracellular receptor-ligand interaction screening using CRISPR activation

MAUDE: Inferring expression changes in sorting-based CRISPR screens

Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens

CRISPR library designer (CLD): Software for multispecies design of single guide RNA libraries

Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-tomesenchymal transition